Isotretinoin oil-based capsule formulation optimization

The Scientific World Journal

Volumn 2013, Issue , 2013, Pages

  Tsai, Pi Ju ^a   Huang, Chi Te ^b   Lee, Chen Chou ^b   Li, Chi Lin ^b   Huang, Yaw Bin ^b   Tsai, Yi Hung ^b   Wu, Pao Chu ^b  

^a I SHOU UNIVERSITY   (Taiwan)

^b KAOHSIUNG MEDICAL UNIVERSITY   (Taiwan)

Author keywords

[No Author keywords available]

Indexed keywords

COCONUT OIL; ISOTRETINOIN; PROPOLIS; SOYBEAN OIL; VEGETABLE OIL; WAX; MICROCAPSULE;

ARTICLE; DRUG CAPSULE; DRUG FORMULATION; DRUG MIXTURE; DRUG RELEASE; DRUG SOLUBILITY; PROCESS OPTIMIZATION; RESPONSE SURFACE METHOD; CHEMISTRY; DRUG DELIVERY SYSTEM; EVALUATION STUDY; HYDROGENATION; MICROCAPSULE; SYNTHESIS; TIME;

CAPSULES; DRUG DELIVERY SYSTEMS; HYDROGENATION; ISOTRETINOIN; PLANT OILS; SOYBEAN OIL; TIME FACTORS; WAXES;

EID: 84884248890     PISSN: None     EISSN: 1537744X     Source Type: Journal    
DOI: 10.1155/2013/856967     Document Type: Article

References (22)

1. Blasi P., Giovagnoli S., Schoubben A., Puglia C., Bonina F., Rossi C., Ricci M., Lipid nanoparticles for brain targeting I. Formulation optimization. International Journal of Pharmaceutics 2011 419 1-2 287 295 2-s2.0-80053567166 10.1016/j.ijpharm.2011.07.035
2. Landín M., Rowe R. C., York P., Advantages of neurofuzzy logic against conventional experimental design and statistical analysis in studying and developing direct compression formulations. European Journal of Pharmaceutical Sciences 2009 38 4 325 331 2-s2.0-70349838064 10.1016/j.ejps.2009.08.004
3. Shi J., Ma F., Wang X., Wang F., Liao H., Formulation of liposomes gels of paeonol for transdermal drug delivery by Box-Behnken statistical design. Journal of Liposome Research 2012 22 4 270 278 10.3109/08982104.2012.690159
4. Subha B., Muthukumar M., Optimization of ozonation process for the reduction of excess sludge production from activated sludge process of sago industry wastewater using central composite design. Scientific World Journal 20122012 2012 239271 10.1100/2012/239271
5. Tsai Y.-H., Fu L.-T., Huang C.-T., Chang J.-S., Huang Y.-B., Wu P.-C., Formulation optimization of estradiol microemulsion using response surface methodology. Journal of Pharmaceutical Sciences 2011 100 10 4383 4389 2-s2.0-80052260703 10.1002/jps.22600
6. van ve Ven H., Vermeersch M., Matheeussen A., Vandervoort J., Weyenberg W., Apers S., Cos P., Maes L., Ludwig A., PLGA nanoparticles loaded with the antileishmanial saponin β -aescin: factor influence study and in vitro efficacy evaluation. International Journal of Pharmaceutics 2011 420 1 122 132 2-s2.0-80054713359 10.1016/j.ijpharm.2011.08.016
7. Villar A. M. S., Naveros B. C., Campmany A. C. C., Trenchs M. A., Rocabert C. B., Bellowa L. H., Design and optimization of self-nanoemulsifying drug delivery systems (SNEDDS) for enhanced dissolution of gemfibrozil. International Journal of Pharmaceutics 2012 431 161 175 2-s2.0-84860559897 10.1016/j.ijpharm.2012.04.001
8. Zhou Y. Z., Alany R. G., Chuang V., Wen J., Optimization of PLGA nanoparticles formulation containing L-DOPA by applying the central composite design. Drug Development and Industrial Pharmacy 2013 39 2 321 330 10.3109/03639045.2012.681054.
9. Lewis G. A., Mathieu D., Phan-Tan-Luu R., Pharmaceutical Experimental Design 1999 New York, NY, USA Dekker
10. Peck G. L., Olsen T. G., Yoder F. W., Prolonged remissions of cystic and conglobate acne with 13-cis-retinoic acid. The New England Journal of Medicine 1979 300 7 329 333 2-s2.0-0018414126
11. Strauss J. S., Isotretinoin (Accutane) for the management of severe nodulocystic acne. Iowa Medicine 1984 74 4 170 172 2-s2.0-0021413852
12. Strauss J. S., Rapini R. P., Shalita A. R., Konecky E., Pochi P. E., Comite H., Exner J. H., Isotretinoin therapy for acne: results of a multicenter dose-response study. Journal of the American Academy of Dermatology 1984 10 3 490 496 2-s2.0-0021341949
13. Nelson A. M., Cong Z., Gilliland K. L., Thiboutot D. M., TRAIL contributes to the apoptotic effect of 13-cis retinoic acid in human sebaceous gland cells. British Journal of Dermatology 2011 165 3 526 533 2-s2.0-80052263711 10.1111/j.1365-2133.2011.10392.x
14. Lumsden K. R., Nelson A. M., Dispenza M. C., Gilliland K. L., Cong Z., Zaenglein A. L., Thiboutot D. M., Isotretinoin increases skin-surface levels of neutrophil gelatinase-associated lipocalin in patients treated for severe acne. British Journal of Dermatology 2011 165 2 302 310 2-s2.0-79960643879 10.1111/j.1365-2133.2011.10362.x
15. USP 34 2011 Rockville, Md, USA U.S.P.C.
16. Ho H.-O., Chen L.-C., Lin H.-M., Sheu M.-T., Penetration enhancement by menthol combined with a solubilization effect in a mixed solvent system. Journal of Controlled Release 1998 51 2-3 301 311 2-s2.0-0032509930 10.1016/S0168-3659(97)00184-3
17. Huang Y.-B., Tsai Y.-H., Lee S.-H., Chang J.-S., Wu P.-C., Optimization of pH-independent release of nicardipine hydrochloride extended-release matrix tablets using response surface methodology. International Journal of Pharmaceutics 2005 289 1-2 87 95 2-s2.0-11844284788 10.1016/j.ijpharm.2004.10. 021
18. Korsmeyer R. W., Gurny R., Doelker E., Mechanisms of potassium chloride release from compressed, hydrophilic, polymeric matrices: Effect of entrapped air. Journal of Pharmaceutical Sciences 1983 72 10 1189 1191 2-s2.0-0020617063
19. Peppas N. A., Analysis of Fickian and non-Fickian drug release from polymers. Pharmaceutica Acta Helvetiae 1985 60 4 110 111 2-s2.0-0021904208
20. Shah V. P., Flynn G. L., Yacobi A., Maibach H. I., Bon C., Fleischer N. M., Franz T. J., Kaplan S. A., Kawamoto J., Lesko L. J., Marty J.-P., Pershing L. K., Schaefer H., Sequeira J. A., Shrivastava S. P., Wilkin J., Williams R. L., Bioequivalence of topical dermatological dosage forms: methods of evaluation of bioequivalence. Pharmaceutical Research 1998 15 2 167 171 2-s2.0-18244412104 10.1023/A:1011941929495
21. FDA, Guidance Fro Industry. Dissolution Testing of Immediate Release Solid Oral Dosage Forms 1997 Rockville, Md, USA FDA
22. Kibbe A. H., Handbook of Pharmaceutical Excipients 2000 3rd London, UK Pharmaceutical Press